CollPlant Biotechnologies Ltd. (CLGN) Earning

$3.57

south_east -$0.09 (-2.33%)
Day's range
$3.52
Day's range
$3.71

CollPlant Biotechnologies Ltd. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.35 -$0.35 -$0.35
Q2 2024 1 -$0.27 -$0.27 -$0.27
Q3 2024 2 -$0.37 -$0.20 -$0.29
Q4 2024 1 -$0.13 -$0.13 -$0.13
Q1 2025 1 -$0.37 -$0.37 -$0.37
Q2 2025 1 $0.29 $0.29 $0.29
Q3 2025 1 -$0.31 -$0.31 -$0.31
Q4 2025 1 -$0.31 -$0.31 -$0.31
Q1 2026 0 $0.00 $0.00 $0.00
Q2 2026 0 $0.00 $0.00 $0.00
Q3 2026 0 $0.00 $0.00 $0.00
Q4 2026 0 $0.00 $0.00 $0.00
Q1 2027 0 $0.00 $0.00 $0.00
Q2 2027 0 $0.00 $0.00 $0.00
Q3 2027 0 $0.00 $0.00 $0.00
Q4 2027 0 $0.00 $0.00 $0.00
Q1 2028 0 $0.00 $0.00 $0.00
Q2 2028 0 $0.00 $0.00 $0.00
Q3 2028 0 $0.00 $0.00 $0.00
Q4 2028 0 $0.00 $0.00 $0.00

CollPlant Biotechnologies Ltd. Earnings Date And Information

CollPlant Biotechnologies Ltd. last posted its earnings results on Tuesday, August 20th, 2024. The company reported $-0.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $0.02. The company had revenue of 4,000 for the quarter and had revenue of 10.96 M for the year. CollPlant Biotechnologies Ltd. has generated $-1 earnings per share over the last year ($-0.62 diluted earnings per share) and currently has a price-to-earnings ratio of -2.34. CollPlant Biotechnologies Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based on prior year's report dates.

CollPlant Biotechnologies Ltd. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/27/2024 Q3 2024 -$0.38 $416,000 $4,000
08/20/2024 Q2 2024 -$0.35 -$0.37 -0.02 $395,500 $249,000
04/04/2024 Q1 2024 -$0.37 $98,000
04/04/2024 Q4 2023 -$0.41 $299,000
11/29/2023 Q3 2023 -$0.13 -$0.38 -0.25 $3.50 M $43,000
05/24/2023 Q2 2023 -$0.29 $0.51 0.8 $3.59 M $10.18 M
03/29/2023 Q1 2023 -$0.21 -$0.35 -0.14 $433,000
03/29/2023 Q4 2022 -$0.21 -$0.37 -0.16 $58,000
12/01/2022 Q3 2022 -$0.31 -$0.39 -0.08 $3.10 M $109,000
05/26/2022 Q2 2022 -$0.14 -$0.40 -0.26 $2.86 M $66,000
03/24/2022 Q1 2022 -$0.26 -$0.37 -0.11 $66,000
11/18/2021 Q4 2021 -$0.28 -$0.35 -0.07 $310,000
11/18/2021 Q3 2021 -$0.28 -$0.29 -0.01 $246,000 $140,000
05/27/2021 Q2 2021 $0.51 -$0.30 -0.81 $3.10 M $691,000
03/26/2021 Q1 2021 -$0.30 $1.20 1.5 $14.50 M
12/01/2020 Q4 2020 $0.92 -$0.42 -1.34 $557,000
12/01/2020 Q3 2020 $0.92 $0.10 -0.82 $4.15 M
04/01/2020 Q2 2020 -$0.13 -$0.28 -0.15 $1.54 M $823,000
04/01/2020 Q1 2020 -$0.13 -$0.24 -0.11 $609,000
04/01/2020 Q4 2019 -$0.13 -$0.74 -0.61 $439,000
 

CollPlant Biotechnologies Ltd. Earnings: FAQ's

When is CollPlant Biotechnologies Ltd.'s earnings date?

CollPlant Biotechnologies Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based off last year's report dates.

How can I listen to CollPlant Biotechnologies Ltd.'s earnings conference call?

The conference call for CollPlant Biotechnologies Ltd.'s latest earnings report can be listened to online.

How can I read CollPlant Biotechnologies Ltd.'s conference call transcript?

The conference call transcript for CollPlant Biotechnologies Ltd.'s latest earnings report can be read online.

How much revenue does CollPlant Biotechnologies Ltd. generate each year?

CollPlant Biotechnologies Ltd. (:CLGN) has a recorded annual revenue of $10.96 M.

How much profit does CollPlant Biotechnologies Ltd. generate each year?

CollPlant Biotechnologies Ltd. (:CLGN) has a recorded net income of $10.96 M. CollPlant Biotechnologies Ltd. has generated $-0.62 earnings per share over the last four quarters.

What is CollPlant Biotechnologies Ltd.'s price-to-earnings ratio?

CollPlant Biotechnologies Ltd. (:CLGN) has a price-to-earnings ratio of -2.34 and price/earnings-to-growth ratio is -0.02.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED